Similar results were obtained in another model of ovarian cancer, in which the phospholipase inhibitor GW4869 was shown to inhibit the exosomal DNA methyltransferase 1 (DNMT1)-mediated cisplatin resistance in cells, and to increase apoptosis (190). Here, DNMT1 is linked to ovarian cancer.